Skip to content

TransMedics Group, Inc.

TMDX

CIK 0001756262

← back to feed
Revenue (TTM)
$66.12M
+10.7% YoY Q1 Apr 2026
Net Income (TTM)
$92.22M
+436.6% YoY Q1 Apr 2026
EPS Diluted (TTM)
$2.48
+382.2% YoY Q1 Apr 2026
Gross Margin
560.5%
Q1 Apr 2026
Operating Margin
152.2%
Q1 Apr 2026
Net Margin
139.5%
Q1 Apr 2026
Free Cash Flow (TTM)
−$99.21M
Q1 Apr 2026
Cash
$330.09M
Q1 Apr 2026
Total Debt
$73.8M
Q1 Apr 2026
Shares Outstanding
34.56M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings